1252-P: Alteration of Alternative Splicing of RYR2 Modulates Insulin Biosynthesis in Pancreatic ß-Cells

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 1252-P
Author(s):  
MAI MAKINO ◽  
ASAKO ITAYA-HIRONAKA ◽  
AKIYO YAMAUCHI ◽  
SUMIYO SAKURAMOTO-TSUCHIDA ◽  
YOSHINORI TAKEDA ◽  
...  
2020 ◽  
Vol 477 (16) ◽  
pp. 3091-3104 ◽  
Author(s):  
Luciana E. Giono ◽  
Alberto R. Kornblihtt

Gene expression is an intricately regulated process that is at the basis of cell differentiation, the maintenance of cell identity and the cellular responses to environmental changes. Alternative splicing, the process by which multiple functionally distinct transcripts are generated from a single gene, is one of the main mechanisms that contribute to expand the coding capacity of genomes and help explain the level of complexity achieved by higher organisms. Eukaryotic transcription is subject to multiple layers of regulation both intrinsic — such as promoter structure — and dynamic, allowing the cell to respond to internal and external signals. Similarly, alternative splicing choices are affected by all of these aspects, mainly through the regulation of transcription elongation, making it a regulatory knob on a par with the regulation of gene expression levels. This review aims to recapitulate some of the history and stepping-stones that led to the paradigms held today about transcription and splicing regulation, with major focus on transcription elongation and its effect on alternative splicing.


1992 ◽  
Vol 67 (02) ◽  
pp. 272-276 ◽  
Author(s):  
C Paul ◽  
E van der Logt ◽  
Pieter H Reitsma ◽  
Rogier M Bertina

SummaryAlthough normally absent from the surface of all circulating cell types, tissue factor (TF) can be induced to appear on circulating monocytes by stimulants like bacterial lipopolysaccharide (LPS) and phorbolesters. Northern analysis of RNA isolated from LPS stimulated human monocytes demonstrates the presence of 2.2 kb and 3.1 kb TF mRNA species. The 2.2 kb message codes for the TF protein. As demonstrated by Northern blot analysis with a variety of TF gene probes, the 3.1 kb message arises from an alternative splicing process which fails to remove 955 bp from intron 1. Because of a stop codon in intron 1 no TF protein is produced from the 3.1 kb transcript. This larger transcript should therefore not be taken into account when comparing TF gene transcription and TF protein levels.


Diabetes ◽  
1984 ◽  
Vol 33 (6) ◽  
pp. 556-561 ◽  
Author(s):  
G. Gold ◽  
M. L. Gishizky ◽  
W. L. Chick ◽  
G. M. Grodsky

Diabetes ◽  
1988 ◽  
Vol 37 (2) ◽  
pp. 160-165 ◽  
Author(s):  
G. Gold ◽  
R. L. Qian ◽  
G. M. Grodsky

Diabetes ◽  
1990 ◽  
Vol 39 (7) ◽  
pp. 871-874 ◽  
Author(s):  
S. Nagamatsu ◽  
R. J. Carroll ◽  
G. M. Grodsky ◽  
D. F. Steiner

Sign in / Sign up

Export Citation Format

Share Document